Limitations of oral busulfan in preparative regimen before hematopoietic stem-cell transplantation.

Haematologica

Volumn 87, Issue 2, 2002, Pages

  Kami, Masahiro ^a   Hamaki, Tamae ^a   Maruta, Yumiko ^a   Miyakoshi, Shigesaburo ^a   Mutou, Yoshitomo ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTICONVULSIVE AGENT; BUSULFAN;

ADULT; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; NAUSEA; ORAL DRUG ADMINISTRATION; PARESTHESIA; SEIZURE; VOMITING;

ADMINISTRATION, ORAL; ADULT; ALKYLATING AGENTS; ANTICONVULSANTS; BUSULFAN; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; NAUSEA; PARESTHESIA; SEIZURES; TRANSPLANTATION CONDITIONING; VOMITING;

EID: 0036484386     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)